Analyst Reco. Alector, Inc.

Equities

ALEC

US0144421072

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
5.25 ^USD	+9.15%		+3.14%	-34.21%

04-17	Certain Restricted Stock Units of Alector, Inc. are subject to a Lock-Up Agreement Ending on 17-APR-2024.	CI
04-17	Certain Options of Alector, Inc. are subject to a Lock-Up Agreement Ending on 17-APR-2024.	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stifel Upgrades Alector to Buy From Hold, Adjusts Price Target to $15 From $8	12-14	MT
Deutsche Bank Initiates Coverage on Alector With Buy Rating, $12 Price Target	12-12	MT
Mizuho Securities Trims Price Target on Alector to $9 From $10, Keeps Buy Rating	11-16	MT
Cantor Fitzgerald Starts Alector at Overweight With $13 Price Target	22/09/23	MT
Mizuho Cuts Price Target on Alector to $10 From $12, Keeps Buy Rating	11/08/23	MT
Stifel Adjusts Price Target on Alector to $8 From $10, Maintains Hold Rating	08/08/23	MT
Barclays Adjusts Price Target on Alector to $12 From $14, Maintains Overweight Rating	05/05/23	MT
Morgan Stanley Adjusts Price Target on Alector to $10 From $11, Maintains Equal-Weight Rating	03/03/23	MT
BTIG Adjusts Price Target on Alector to $16 From $54, Keeps Buy Rating	02/03/23	MT
Mizuho Adjusts Price Target on Alector to $12 From $15, Keeps Buy Rating	02/03/23	MT
Citigroup Adjusts Price Target on Alector to $12 From $17, Maintains Buy Rating	01/03/23	MT
Morgan Stanley Adjusts Price Target on Alector to $11 From 13, Maintains Equalweight Rating	24/01/23	MT
Citigroup Adjusts Price Target on Alector to $17 From $19, Maintains Buy Rating	10/11/22	MT
Morgan Stanley Downgrades Alector to Equalweight From Overweight, Cuts Price Target to $13 From $27	09/09/22	MT
Citigroup Adjusts Alector's Price Target to $19 From $34, Reiterates Buy Rating	11/07/22	MT
Mizuho Securities Initiates Alector at Buy with $15 Price Target	07/07/22	MT
Mizuho Initiates Alector with Buy Rating, $15 Price Target, Represents 'Classic' Risk/Reward in Biotech	06/07/22	MT
Goldman Sachs Adjusts Alector's Price Target to $6 from $9, Keeps Sell Rating	24/05/22	MT
Barclays Adjusts Alector's Price Target to $14 from $42, Keeps Overweight Rating	11/05/22	MT
Goldman Sachs Initiates Coverage on Alector With Sell Rating, $9 Price Target	13/04/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Alector, Inc.

Equities

ALEC

US0144421072

Analyst Reco.

Filters